Health Care & Life Sciences » Biotechnology | BioRestorative Therapies Inc.

BioRestorative Therapies Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
Depreciation, Depletion & Amortization
104.80
96.70
213.80
258.40
259.30
240.40
Other Funds
25.00
25.00
177.00
72.00
15.00
7,218.60
Funds from Operations
4,196.70
3,709.50
5,180.30
5,183.60
4,675.10
5,058.90
Changes in Working Capital
1,524.30
481.60
2,058.30
180.90
821.30
45.80
Net Operating Cash Flow
2,672.40
3,227.90
3,122.10
5,002.70
3,853.80
5,104.60
Capital Expenditures
11.20
168.40
483.10
188.80
3.60
Sale of Fixed Assets & Businesses
-
1.00
-
-
-
Net Investing Cash Flow
11.20
167.40
483.10
188.80
3.60
Issuance/Reduction of Debt, Net
1,448.50
592.90
1,205.00
1,417.50
2,212.00
Net Financing Cash Flow
2,884.30
3,285.90
3,679.90
5,056.70
4,277.30
Net Change in Cash
200.70
109.30
74.80
134.70
419.90
Free Cash Flow
2,683.60
3,396.20
3,530.10
5,191.40
3,857.40
Change in Capital Stock
1,410.80
2,718.00
2,297.80
3,711.20
2,080.30

About BioRestorative Therapies

View Profile
Address
40 Marcus Drive
Melville New York 11747
United States
Employees -
Website http://www.biorestorative.com
Updated 07/08/2019
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.